Reply to F.E. Vera-Badillo et al Correspondence
| Authors: | Rosenberg, J. E.; Petrylak, D. P. |
| Title: | Reply to F.E. Vera-Badillo et al |
| Keywords: | protein expression; treatment outcome; treatment response; overall survival; paclitaxel; letter; biological marker; patient assessment; drug research; transitional cell carcinoma; programmed death 1 ligand 1; cisplatin derivative; priority journal; evaluation study; enfortumab vedotin; nectin |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 6 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-02-20 |
| Start Page: | 651 |
| End Page: | 652 |
| Language: | English |
| DOI: | 10.1200/jco.19.02830 |
| PUBMED: | 31880968 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Letter -- Export Date: 1 April 2020 -- Source: Scopus |
